Literature DB >> 18466690

A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China.

Chao Chen1, Tie-gang Zhang, Jing-guo He, Jiang Wu, Li-juan Chen, Jun-feng Liu, Xing-huo Pang, Jie Yang, Zhu-jun Shao, Ying-chun Huang.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18466690

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  6 in total

1.  Neisseria meningitidis serogroup X sequence type 767 in Turkey.

Authors:  Abdullah Kiliç; Orhan Bedir; A Celal Basustaoglu; Holly B Bratcher; Keith A Jolley; Gurkan Mert
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

2.  Neisseria meningitidis serogroup X sequence type 2888, Italy.

Authors:  Cecilia Fazio; Stefania Starnino; Marina Dal Solda; Tonino Sofia; Arianna Neri; Paola Mastrantonio; Paola Stefanelli
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

Review 3.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

4.  Neisseria meningitidis strain of unknown serogroup, China.

Authors:  Haijian Zhou; Zhujun Shao; Qian Li; Li Xu; Jiang Wu; Biao Kan; Jianguo Xu
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

5.  Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis.

Authors:  Juan Xu; Yuquan Chen; Mengmeng Yue; Jianxing Yu; Fuyi Han; Li Xu; Zhujun Shao
Journal:  Hum Vaccin Immunother       Date:  2022-06-10       Impact factor: 4.526

6.  An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.

Authors:  Timm Fiebig; Maria Rosaria Romano; Davide Oldrini; Roberto Adamo; Marta Tontini; Barbara Brogioni; Laura Santini; Monika Berger; Paolo Costantino; Francesco Berti; Rita Gerardy-Schahn
Journal:  NPJ Vaccines       Date:  2016-11-15       Impact factor: 7.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.